Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
A review exploring the translational perspective of artificial intelligence in drug discovery and formulation development | Synapse
March 3, 2026
A review exploring the translational perspective of artificial intelligence in drug discovery and formulation development
BA
Babita Agarwal
Marathwada Agricultural University
SG
Saurabh Gaware
Marathwada Agricultural University
NM
Namdev More
Cedars-Sinai Medical Center
Ver todo
Puntos clave
AI can streamline the drug discovery process, enhancing efficiency in formulation development.
Machine learning algorithms have shown promise in predicting successful drug interactions, improving overall outcomes.
The review discusses the potential of AI to reduce costs and time involved in bringing new medications to market.
These advancements may enable more targeted therapies, paving the way for personalized medicine.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Agarwal et al. (Sun,) studied this question.
synapsesocial.com/papers/69a767a5badf0bb9e87e1c36
https://doi.org/https://doi.org/10.1016/j.pharma.2026.01.007
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir